Staphylococci are facultative anaerobes (growing in both oxygen-rich and oxygen-poor environments), nonmotile, and non-spore-forming. They are classified primarily by their ability to clot blood plasma via the enzyme coagulase: coagulase-positive species (most notably S. aureus) are the most virulent, while coagulase-negative species (e.g., S. epidermidis, S. saprophyticus) are generally less aggressive but still clinically significant, especially in immunocompromised patients or those with implanted devices. At least 30 species have been identified, 11 of which are human commensals. S. aureus can colonize the nasal passages, skin, and mucous membranes asymptomatically in healthy individuals, but can trigger infections ranging from furuncles and impetigo to pneumonia, endocarditis, osteomyelitis, and toxic shock syndrome. Antibiotic resistance, particularly methicillin-resistant S. aureus (MRSA), is a major global public health challenge.
greek
Coined in 1882 by Scottish surgeon Alexander Ogston (1844-1929), who first described the bacteria in pus from a surgical knee abscess, noting they looked like “bunches of grapes.” He combined: Greek σταφυλή (staphylē) — “bunch of grapes,” possibly from PIE; stabh- (“post, stem; to support”)Greek κόκκος (kókkos) — “berry, grain, seed.” The term was published in Modern Latin as Staphylococcus in 1882, with English usage following by 1887. In 1884, German physician Friedrich Julius Rosenbach further differentiated S. aureus (Latin aureus = “golden”) from S. albus (Latin albus = “white”), the latter later renamed S. epidermidis. Combining form: o- also independently means “uvula” (the soft tissue hanging at the back of the throat, which resembles a grape